http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2394030-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a85b42c9c9c3b83f2d3ca1eb3c2b25e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 |
| filingDate | 2004-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a0891839be6a766fe5dd3ee27d2c23a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38d2ff048b957028245a10225da7ffbb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_356b171e5595e0226bf760f7624cedbe |
| publicationDate | 2010-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2394030-C2 |
| titleOfInvention | AMINOSUBSTITUTED DIARYL [a, d] CYCLOHEPTANE ANALOGUES AS MUSCARINIC AGONISTS AND METHOD OF TREATING PSYCHONEUROLOGICAL DISORDERS |
| abstract | FIELD: chemistry. n SUBSTANCE: present invention relates to a compound having the structural formula I , or its pharmaceutically acceptable salt, ester or amide, where A has the structure , where each bond in A, represented by a dotted and a solid line, represents a carbon-carbon single bond; each of a, b and c is a carbon atom; each of e, f, g and h is a carbon atom; X is nitrogen; X' is C; L is absent; each n equals 1; Y is nitrogen; W is nitrogen; R 1 is hydrogen; each of R 2 , R 3 and R 4 is a hydrogen atom; each of R 6 , R 8 and R 9 is a hydrogen atom; R 5 is selected from a group consisting of halogen, C 1-6 alkyl, optionally substituted with a hydroxy group, and C 1-6 alkoxy; R 7 is selected from a group consisting of halogen, C 1-6 alkyl and perhalogenalkyl; Z is selected from a group consisting of NR 11 , oxygen and CH 2 ; R 11 is hydrogen; and each bond in formula I, represented by a dotted and a solid line, is a carbon-carbon double bond. The invention also relates to a method for synthesis of a formula V compound, a pharmaceutical composition based on a formula I compound, methods of treating psychoneurological disorders, a pharmaceutical composition containing a formula I compound and a psychoneurological agent. n EFFECT: obtaining novel compounds useful for modulating muscarine receptor activity. n 37 cl, 1 tbl, 141 ex |
| priorityDate | 2003-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 724.